Pathology of Sex Cord Stromal Testis Tumor 

No Results

No Results

processing….

Testicular sex cord stromal tumors include Leydig cell tumors, Sertoli cell tumors, and granulosa cell tumors. Leydig cell tumors (see the image below) are derived from normal Leydig cells that produce testosterone and are located in the interstitium of the testis. ^{[1, 2, 3]}

A typical Sertoli cell tumor (see the images below) is a tumor derived from Sertoli cells, located within seminiferous tubules, which help support spermatogenesis. Sclerosing Sertoli cell tumor is a rare variant of the Sertoli cell tumor. Large-cell calcifying Sertoli cell tumor is also a rare variant of a Sertoli cell tumor. ^{[4, 5, 6, 7]}

Granulosa cells are not native to the testis. Adult-type granulosa cell tumors of the testicle are much less common than in the adult female ovary. The juvenile type of this condition is a rare sex cord stromal tumor that occurs in males in the first few months of life. ^[8]

Leydig cell tumors constitute about 3% of testicular neoplasms and occur in both adults (80% of cases) and children. Sertoli cell tumors account for less than 1% of testicular tumors, and they occur both in children (15% of cases) and in middle-aged adults and can be malignant (about 10% of cases) in both. ^{[4, 9, 10]}

Boys with Leydig cell sex cord stromal tumors present with endocrinologic symptoms (virilization, gynecomastia), while men present with a testicular mass; some (10-30%) have gynecomastia. In boys, Leydig cell tumors are benign. However, in men, 10-17% of these tumors are malignant. Tumors are unilateral, with rare exceptions.

Patients with Sertoli cell sex cord stromal tumors present with a testicular mass, and estrogen production by the tumor can result in gynecomastia and impotence. The treatment is orchiectomy. Estrogens secreted by the Sertoli cells may promote the female phenotype. In sclerosing Sertoli cell tumor, patients present with a testicular mass and without endocrinologic symptoms. No malignant cases have been reported.

In large-cell calcifying Sertoli cell tumor, patients are young, with age at diagnosis ranging from 16-37 years. The tumor occurs both as a part of the Carney complex and in patients with Peutz-Jeghers syndrome. In this setting, the tumor tends to be multifocal.

Malignant tumors may occur and are usually sporadic (with one report of a malignant tumor associated with Carney syndrome). ^[4]

In patients with granulosa cell tumor, the average age is 42 years, and 20% of male patients present with gynecomastia. Of 4 patients reported with metastasis, 2 died.

Leydig cells impart a yellow to yellow-tan color; the tumor is solid and lobulated. Malignant tumors tend to be larger (>5 cm) than benign tumors. Necrosis can be seen in malignant tumors.

Tumors are well-circumscribed, solid-pale-yellow, or white-to-gray masses. Large size and necrosis are worrisome features for malignancy. Sclerosing Sertoli cell tumor is similar to a typical Sertoli cell tumor. In large-cell calcifying Sertoli cell tumor, benign tumors are small (usually < 2 cm), yellow, tan, or white nodules confined to the testicle. Malignant tumors are larger and may have areas of necrosis.

The mass is lobulated, firm, and uniformly yellow-gray. Tumors of the juvenile type are small and solid and contain multiple small cysts.

Leydig cells vary in size but usually have round nuclei, single prominent nucleoli, and abundant eosinophilic cytoplasm or abundant clear cytoplasm (see the image below). ^{[11, 12, 13]} Reinke crystals are present in 40-70% of cases, and lipochrome can be abundant in some cases. Electron microscopy shows mitochondria with tubular cristae. Rarely, adipose differentiation or spindle cell growth is noted.

Malignant features include large size (>5 cm), increased mitotic activity (>5/10 hpf), necrosis, angiolymphatic invasion, and invasion of surrounding structures, such as tunica, epididymis, and spermatic cord. Malignant behavior is difficult to predict based on histologic features.

These tumors do not respond to radiation; thus, the differential diagnosis with seminoma is crucial. Lack of inhibin-alpha reactivity suggests a germ cell tumor. Differential diagnosis includes testicular tumor of adrenogenital syndrome, which is bilateral, dark brown grossly, and, less often, immunoreactive with inhibin-alpha. Leydig cell hyperplasia is multifocal rather than forming a single mass and does not efface seminiferous tubules.

Sertoli cell tumors are typically composed of solid tubules containing Sertoli cells. ^{[11, 12, 13]} Tubules can contain lumina. Also, cells may be arranged in cords (see the first image below), solid nests, and sheets. By electron microscopy, Charcot-Bottcher filaments (perinuclear aggregates of intermediate filaments) are pathognomonic of Sertoli cells or Sertoli cell differentiation. In sclerosing Sertoli cell tumor, cords, nests, and tubules of Sertoli cells are present within a fibrotic stroma (see the second image below).

Malignant behavior can be difficult to predict. Features worrisome for malignancy are identical to those seen in Leydig cell tumors.

In large-cell calcifying Sertoli cell tumor, neoplastic cells are arranged in sheets, small nests, and cords, and they are present in a myxoid to fibrous stroma. Dystrophic calcifications, including psammomatous calcifications, are present. Malignant tumors are large and exhibit extratesticular spread, increased mitotic activity, necrosis, and angiolymphatic invasion.

The proliferation of Sertoli cells may also be seen in androgen insensitivity syndrome in XY male patients with male, female, or ambiguous phenotype (“tubular adenoma” or Sertoli cell adenoma; see the first image below) and in the cryptorchid testis (Sertoli cell nodule or Pick adenoma; see the second image below). Malignant cases are often misinterpreted as seminoma, and immunostains may help. ^[14]

Granulosa cell tumor is microfollicular with a few larger cysts. Call-Exner bodies may be seen. Cells have scant cytoplasm and angular nuclei. They may have nuclear grooves. The juvenile type has sheets of spindle cells with abundant cytoplasm intermixed with follicle-like cystic spaces. Hyalinized collagenous stroma is also a feature in cellular areas. ^[15]

Inhibin-alpha is reactive in 100% of cases. ^[12] The tumor shows variable reactivity with cytokeratins and rarely reacts with S-100 protein, chromogranin, synaptophysin, and estrogen and progesterone receptors.

Inhibin-alpha is a specific marker, but Sertoli cell tumors are less consistently reactive than Leydig cell tumors (91% in Iczkowski’s series, but 47% of cases in combined series). ^[12] Tumors can be positive for synaptophysin, chromogranin, and S-100 protein and with cytokeratin AE1/3 and CAM5.2 in 64-100% of cases. ^[16]

In large-cell calcifying Sertoli cell tumor, S-100 is positive, EMA is negative, and cytokeratin is variable (usually negative to weak staining).

Staging for testicular sex cord stromal tumors is the same as for germ cell tumors.

Featherstone JM, Fernando HS, Theaker JM, Simmonds PD, Hayes MC, Mead GM. Sex cord stromal testicular tumors: a clinical series–uniformly stage I disease. J Urol. 2009 May. 181(5):2090-6; discussion 2096. [Medline].

Heer R, Jackson MJ, El-Sherif A, Thomas DJ. Twenty-nine Leydig cell tumors: histological features, outcomes and implications for management. Int J Urol. 2010 Oct. 17(10):886-9. [Medline].

Di Tonno F, Tavolini IM, Belmonte P, et al. Lessons from 52 patients with leydig cell tumor of the testis: the GUONE (North-Eastern Uro-Oncological Group, Italy) experience. Urol Int. 2009. 82(2):152-7. [Medline].

Sesterhenn IA, Cheville J, Woodward PJ, et al. Sex cord/gonadal stromal tumours. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004. 250-5.

Vallangeon BD, Eble JN, Ulbright TM. Macroscopic sertoli cell nodule: a study of 6 cases that presented as testicular masses. Am J Surg Pathol. 2010 Dec. 34(12):1874-80. [Medline].

Tetu B, Ro JY, Ayala AG. Large cell calcifying Sertoli cell tumor of the testis. A clinicopathologic, immunohistochemical, and ultrastructural study of two cases. Am J Clin Pathol. 1991 Dec. 96(6):717-22. [Medline].

Zukerberg LR, Young RH, Scully RE. Sclerosing Sertoli cell tumor of the testis. A report of 10 cases. Am J Surg Pathol. 1991 Sep. 15(9):829-34. [Medline].

Hanson JA, Ambaye AB. Adult testicular granulosa cell tumor: a review of the literature for clinicopathologic predictors of malignancy. Arch Pathol Lab Med. 2011 Jan. 135(1):143-6. [Medline].

Kim I, Young RH, Scully RE. Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature. Am J Surg Pathol. 1985 Mar. 9(3):177-92. [Medline].

Cecchetto G, Alaggio R, Bisogno G, et al. Sex cord-stromal tumors of the testis in children. A clinicopathologic report from the Italian TREP project. J Pediatr Surg. 2010 Sep. 45(9):1868-73. [Medline].

Shanks JH, Iczkowski KA. Non-germ cell tumours of the testis. Curr Diagn Pathol. 2002. 8:83-93.

Iczkowski KA, Bostwick DG, Cheville JC. Immunohistochemical profile of Sertoli and Leydig cell testicular tumors. Mod Pathol. 1998. 11:774-9.

Ulbright TM. The most common, clinically significant misdiagnoses in testicular tumor pathology, and how to avoid them. Adv Anat Pathol. 2008 Jan. 15(1):18-27. [Medline].

Henley JD, Young RH, Ulbright TM. Malignant Sertoli cell tumors of the testis: a study of 13 examples of a neoplasm frequently misinterpreted as seminoma. Am J Surg Pathol. 2002 May. 26(5):541-50. [Medline].

Chen L, Yang B. 14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors. Int J Gynecol Pathol. 2013 Mar. 32(2):156-62. [Medline].

Esber CM, Shabsigh A, Zynger DL. Sclerosing Sertoli cell tumor without expression of typical sex cord stromal tumor markers: case report and literature review. Pathol Res Pract. 2012 Feb 15. 208(2):121-5. [Medline].

Frank N Moore, MD Associate Pathologist, General Surgical and Hematopathology, Colorado Pathology Consultants

Frank N Moore, MD is a member of the following medical societies: American Society for Clinical Pathology, College of American Pathologists, United States and Canadian Academy of Pathology

Disclosure: Nothing to disclose.

Liang Cheng, MD Professor of Pathology and Urology, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine; Chief, Genitourinary Pathology Service, Indiana University Health

Liang Cheng, MD is a member of the following medical societies: American Association for Cancer Research, American Urological Association, College of American Pathologists, United States and Canadian Academy of Pathology, International Society of Urological Pathology, Arthur Purdy Stout Society

Disclosure: Nothing to disclose.

Kenneth A Iczkowski, MD Pathology Laboratory Director, Urology Specialists of America, Columbus, OH

Kenneth A Iczkowski, MD is a member of the following medical societies: College of American Pathologists and United States and Canadian Academy of Pathology

Disclosure: Nothing to disclose.

Pathology of Sex Cord Stromal Testis Tumor 

Research & References of Pathology of Sex Cord Stromal Testis Tumor |A&C Accounting And Tax Services
Source

Share on Facebook

Tweet

Follow us